| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Phillip Frost
Also a director
CEO & Chairman
Title from the Form 4 dated Nov 21, 2025
|
89 | Not stated | $1,854,000 | |
|
Adam Logal
Senior Vice President, Chief Financial Officer, Chief Accounting Officer, and Treasurer
|
48 |
Since 2014
12 years
|
$1,539,000 | |
|
Elias A. Zerhouni
Also a director
Vice Chairman and President
Title from the Form 4 dated May 27, 2025
|
75 | Not stated | $1,764,000 | |
|
Jane H. Hsiao
Also a director
Vice Chairman & CTO
Title from the Form 4 dated May 27, 2025
|
78 | Not stated | $1,764,000 | |
|
Gary J. Nabel
Also a director
Chief Innovation Officer
Title from the Form 4 dated May 27, 2025
|
72 | Not stated | Not reported | |
|
Charles W. Bishop
Chief Executive Officer of OPKO Renal
|
74 |
Since 2013
13 years
|
Not reported | |
|
Steven D. Rubin
Also a director
Executive VP-Administration
Title from the Form 4 dated Jul 24, 2026
|
65 | Not stated | $1,574,000 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...